Panacea Life Sciences Holdings, Inc. (PLSH)
OTCMKTS · Delayed Price · Currency is USD
0.0750
0.00 (0.00%)
Jul 24, 2026, 4:00 PM EST

PLSH Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingMar '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Revenue
2.762.381.632.069.022.2
Revenue Growth
50.38%46.59%-21.01%-77.16%310.19%-
Gross Profit
-3.87-4.09-4.56-4.42-2.45-1.68
Operating Income
-5.31-5.55-5.65-5.94-5.26-2.67
Net Income
-7.67-8.02-9.14-4.78-5.23-2.81
Earnings Per Share
-0.45-0.48-0.62-0.27-0.31-0.16
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingMar '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Cash & Investments
0.120.121.113.812.949.94
Total Debt
21.8621.6518.971522.8918.77
Net Cash (Debt)
-21.74-21.53-17.85-11.18-19.95-8.83
Net Cash Growth
------
Net Cash Per Share
-1.28-1.29-1.20-0.63-1.18-0.50

Cash Flow & CapEx

Fiscal YearTTMFY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingMar '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Operating Cash Flow
-1.57-1.52-2.4-3.92-7.65-3.89
Capital Expenditures
-0.06-0.07-0.24-0.16-3.2-6.98
Free Cash Flow
-1.62-1.59-2.64-4.09-10.85-10.87
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingMar '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Gross Margin
-139.86%-171.48%-280.20%-214.53%-27.19%-76.56%
Operating Margin
-192.25%-232.55%-347.41%-288.26%-58.31%-121.42%
Pretax Margin
-277.51%-336.08%-561.94%-232.20%-58.02%-127.88%
Profit Margin
-277.51%-336.08%-561.94%-232.20%-58.02%-127.88%
FCF Margin
-58.71%-66.66%-162.47%-198.34%-120.28%-494.42%

Valuation

Fiscal YearCurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingJul '26 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
PS Ratio
1.941.110.654.92--